title: Impact of bivalirudin and Genous stent in patients with acute myeloid leukemia undergoing emergency percutaneous coronary angioplasty for acute coronary syndrome [corrected].
authors.forename: G
authors.initials: G
authors.lastname: Galasso
authors.forename: T
authors.initials: T
authors.lastname: Niglio
authors.forename: S
authors.initials: S
authors.lastname: De Luca
authors.forename: C
authors.initials: C
authors.lastname: De Biase
authors.forename: V
authors.initials: V
authors.lastname: Parisi
authors.forename: F
authors.initials: F
authors.lastname: Piscione
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy*; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000991:Antithrombins / Q000627:therapeutic use*; D006629:Hirudins; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D015607:Stents
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin